Clinical Trial

MDT-0123 Japan Study

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to compare the efficacy and safety of this investigational device with autologous iliac bone graft (ICBG) in patients who are deemed to require bone fusion through spinal fixation at two levels (ALIF or OLIF) due to disc degeneration or spinal deformity in the lumbosacral spine (L2-S1) for intervertebral support and correction with the aim of stabilizing the spine.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-08
critical Phase changed: not applicable -> Phase 3 2026-07-08
Trial Details
NCT Number NCT07414745
Lead Sponsor Medtronic Spinal and Biologics
Conditions Disc Degeneration, Spinal Deformity
Enrollment 140 participants
Start Date 2026-04-24
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-07